3,5-Bis-tert-butylsalicylic acid

Catalog No.: 
ACQVBF156
CAS No.: 
19715-19-6
Molecular Formula: 
C15H22O3
Molecular Weight: 
250.34
3,5-Bis-tert-butylsalicylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g95%$139.00In stockInquiry
1000g95%$232.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,5-Bis-tert-butylsalicylic acid
IUPAC Name3,5-di-tert-butyl-2-hydroxybenzoic acid
MDL No.MFCD00059058
Molecular FormulaC15H22O3
Molecular Weight250.34
SMILESO=C(O)C1=CC(C(C)(C)C)=CC(C(C)(C)C)=C1O
InChI KeyZWQBZEFLFSFEOS-UHFFFAOYSA-N
Synonym3,5-Bis-tert-butylsalicylic acid | (5-methyl-1H-1,3-benzodiazol-2-yl)methanol | 3,5-Ditertbutyl salicylic acid | CS-0154923 | 3-phenyl-2-sulfanyl-3,4-dihydroquinazolin-4-one | 3,5-bis(1,1-dimethylethyl)-2-hydroxybenzoic acid | 3,5-di-tertbutylsalicylic ac
CAS No.19715-19-6
PubChem CID88208

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQVBF156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQVBF156 route product structure diagram
    ACQVBF15619715-19-6In Stock
Inquiry

2. ACQVBF156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQVBF156 route product structure diagram
    ACQVBF15619715-19-6In Stock
Inquiry

3. ACQVBF156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQVBF156 route product structure diagram
    ACQVBF15619715-19-6In Stock
Inquiry

Comments (0)